Replies to post #1150 on Combimatrix (CBMX)

[ash111]

CBMX O/S to more than doubled per FORM POS AM and im not sure this alone will solve other problems:

?
our
ability to continue as a going concern;
?
our
ability to maintain compliance with NASDAQ’s continued listing requirements;
?
our
ability to obtain additional financing for working capital on acceptable terms and in a timely manner;
?
our
ability to successfully increase the volume of our existing tests, expand the number of tests offered by our laboratory, increase
the number of
customers and partners and improve reimbursement for our testin
our
ability to attract and retain a qualified sales force and key technical personnel;
?
our
ability to successfully develop and introduce new technologies and services;
?
rapid
technological change in our markets;
?
supply
availability;
?
our
ability to bill and obtain reimbursement for highly specialized tests;
?
the
rate of growth of the
in vitro
fertilization, or IVF, diagnostic testing market;
?
our
ability to comply with regulations to which our business is subject, including changes in coding and reimbursement methods;
?
legislative,
regulatory and competitive developments in markets in which we and our subsidiaries operate;
?
our
limited market capitalization